The Leukemia & Lymphoma Society® (LLS) is the global leader in the fight against blood cancer. The LLS mission is to cure blood cancer and improve the quality of life of all patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care. 
 
Founded in 1949 and headquartered in Rye Brook, NY, LLS has regions throughout the United States and Canada.

The University of Melbourne is Australia’s leading collaborative institution, and our reputation is grounded in our outstanding contributions to research.

We influence policy, create culturally significant works, challenge our understanding of the world around us and drive new technology to improve the health and wellbeing of our people and planet.

Our research is a global magnet for prospective students, graduate researchers, academics and partners. We work across seven campuses and three innovation precincts including the Southbank Arts Precinct, Melbourne Connect and the Melbourne Biomedical Precinct. Currently we are actively working on 5,000 externally funded research projects in a range of fields including Indigenous knowledge, human rights law, quantum computing, vaccine development, and fine arts.

One way or another, cancer touches all our lives. Which is why nothing is more personal, or more urgent, than our goal to find cures for cancer and to deliver on our purpose: breakthroughs that change patients’ lives.